Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substanti…
What to know about DOC
Healthpeak Properties, Inc. is a large Real Estate company with a mixed financial profile. It scores well on cash flow and growth, but size is worth keeping an eye on.
Should you consider DOC?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Healthpeak Properties, Inc. is a large-cap Real Estate company with a mixed overall financial profile — it ranks near the bottom of Real Estate stocks (24 of 31).
-
Profit margins are thin compared to most S&P 500 peers — the company keeps less of each dollar it earns than the average. Watch for signs of margin improvement.
-
The stock trades at a premium — investors are paying more per dollar of earnings than most S&P 500 companies. That's fine if strong growth justifies it, but leaves little room for disappointment.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
There is a small dividend (0.06%), but income-focused investors will likely find better yields elsewhere in the market.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
Analyst sentiment is cautious and short interest is relatively elevated — meaning some professional investors are actively betting the price will fall. Worth understanding why.
-
There are several areas of concern. This may suit investors with a higher risk tolerance or a specific contrarian view on the Real Estate sector.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how DOC compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 61.13 | Below avg |
| Forward P/E | 130.40 | Below avg |
| PEG Ratio | 4.32 | Below avg |
| Price to Sales | 4.69 | Average |
| Price to Book | 1.74 | Top 25% |
| EV/EBITDA | 15.95 | Average |
| Earnings Yield | 1.64% | Below avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 58.33% | Above avg |
| Operating Margin | 12.31% | Average |
| Net Profit Margin | 7.73% | Average |
| Return on Equity | 2.80% | Below avg |
| Return on Invested Capital | 1.50% | Below avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 7.10% | Average |
| Revenue Growth (3Y CAGR) | 11.05% | Top 25% |
| EPS Growth (YoY) | 363.90% | Top 25% |
| Free Cash Flow Growth | 16.95% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 2.04 | Top 25% |
| Debt to Equity | 1.18 | Average |
| Interest Coverage | 1.93 | Below avg |
| Altman Z-Score | — | N/A |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 6.07% | Top 25% |
| Payout Ratio | 381.26% | Below avg |
| Dividend Growth (5Y) | -12.60% | Below avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 9.15% | Top 25% |
| OCF to Sales | 42.94% | Top 25% |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 1.03 | Average |
| Volatility (30-Day) | 24.34% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 5.24% | Average |
| Avg. Analyst Rating | 2.32 | Average |
| Target Upside % | 8.78% | Average |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 13.49B | Below avg |
How does DOC compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to DOC — based on their financial profile.